应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TGTX TG Therapeutics Inc.
交易中 04-23 12:11:14 EDT
39.89
+1.90
+5.00%
最高
40.35
最低
38.47
成交量
86.85万
今开
38.75
昨收
37.99
日振幅
4.95%
总市值
62.66亿
流通市值
58.24亿
总股本
1.57亿
成交额
3,425万
换手率
0.59%
流通股本
1.46亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Tg Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%报39.89美元
市场透视 · 14:30
Tg Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%报39.89美元
Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元,同比增加84.53%
市场透视 · 03-08
Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元,同比增加84.53%
Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元
市场透视 · 03-06
Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元
Tg Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 03-04
Tg Therapeutics, Inc.盘中异动 股价大涨5.00%
TG Therapeutics 2024年第四季度GAAP每股收益$0.15,与预期一致,销售额$108.19M超$99.95M预期
财报速递 · 03-03
TG Therapeutics 2024年第四季度GAAP每股收益$0.15,与预期一致,销售额$108.19M超$99.95M预期
Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%
市场透视 · 02-28
Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%
Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
市场透视 · 02-24
Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元
市场透视 · 01-31
Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元
Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%
市场透视 · 01-27
Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%
Tg Therapeutics, Inc.盘中异动 股价大涨5.03%报30.50美元
市场透视 · 01-24
Tg Therapeutics, Inc.盘中异动 股价大涨5.03%报30.50美元
Tg Therapeutics, Inc.盘中异动 股价大涨7.17%报29.66美元
市场透视 · 01-14
Tg Therapeutics, Inc.盘中异动 股价大涨7.17%报29.66美元
Tg Therapeutics, Inc.盘中异动 早盘急速下挫5.06%
市场透视 · 01-13
Tg Therapeutics, Inc.盘中异动 早盘急速下挫5.06%
Tg Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报32.50美元
市场透视 · 2024-12-20
Tg Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报32.50美元
Tg Therapeutics, Inc.盘中异动 股价大跌5.03%报31.88美元
市场透视 · 2024-12-18
Tg Therapeutics, Inc.盘中异动 股价大跌5.03%报31.88美元
Tg Therapeutics, Inc.盘中异动 大幅下跌5.06%
市场透视 · 2024-12-03
Tg Therapeutics, Inc.盘中异动 大幅下跌5.06%
Tg Therapeutics, Inc.盘中异动 快速上涨5.05%报36.84美元
市场透视 · 2024-11-25
Tg Therapeutics, Inc.盘中异动 快速上涨5.05%报36.84美元
Tg Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报32.66美元
市场透视 · 2024-11-13
Tg Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报32.66美元
异动解读 | TG Therapeutics Inc.股价大涨5.28% 业绩和产品线发展或为推手
异动解读 · 2024-11-11
异动解读 | TG Therapeutics Inc.股价大涨5.28% 业绩和产品线发展或为推手
Tg Therapeutics, Inc.盘中异动 股价大涨5.14%报30.29美元
市场透视 · 2024-11-11
Tg Therapeutics, Inc.盘中异动 股价大涨5.14%报30.29美元
Tg Therapeutics, Inc.2024财年第三财季实现净利润3.88百万美元,同比减少96.60%
市场透视 · 2024-11-10
Tg Therapeutics, Inc.2024财年第三财季实现净利润3.88百万美元,同比减少96.60%
加载更多
公司概况
公司名称:
TG Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司,专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外,TG还获得了美国食品药品监督管理局(FDA)的BRIUMVI(ublituximab-xiiy)批准,用于治疗成人复发性多发性硬化症(RMS)患者,包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。
发行价格:
--
{"stockData":{"symbol":"TGTX","market":"US","secType":"STK","nameCN":"TG Therapeutics Inc.","latestPrice":39.89,"timestamp":1745424672683,"preClose":37.99,"halted":0,"volume":868475,"delay":0,"floatShares":146000000,"shares":157070575,"eps":0.15,"marketStatus":"交易中","change":1.9,"latestTime":"04-23 12:11:14 EDT","open":38.75,"high":40.35,"low":38.47,"amount":34254743.55085,"amplitude":0.049487,"askPrice":39.9,"askSize":130,"bidPrice":39.81,"bidSize":56,"shortable":3,"etf":0,"ttmEps":0.15,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745438400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1128657600000,"exchange":"NASDAQ","adjPreClose":37.99,"preHourTrading":{"tag":"盘前","latestPrice":38.7,"preClose":37.99,"latestTime":"09:26 EDT","volume":9244,"amount":359117.04077200004,"timestamp":1745414818074},"postHourTrading":{"tag":"盘后","latestPrice":38.61,"preClose":37.99,"latestTime":"19:50 EDT","volume":47364,"amount":1810608.7533,"timestamp":1745365820131},"volumeRatio":1.007257,"impliedVol":0.8995,"impliedVolPercentile":0.864},"requestUrl":"/m/hq/s/TGTX","defaultTab":"news","newsList":[{"id":"2529382886","title":"Tg Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%报39.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529382886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529382886?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:30","pubTimestamp":1745418613,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时30分,Tg Therapeutics, Inc.股票出现波动,股价大幅拉升5.00%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.63%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Plus Therapeutics, Inc.较为活跃,换手率分别为5276.52%、479.57%、69.69%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp,振幅分别为223.08%、74.87%、69.86%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223013aa2c790b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223013aa2c790b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4139","BK4007","BK4585"],"gpt_icon":0},{"id":"2518744086","title":"Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元,同比增加84.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518744086?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449668,"startTime":"0","endTime":"0","summary":"3月9日,Tg Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为23.38百万美元,同比增加84.53%;其中营业收入为3.29亿美元,同比增加40.60%,每股基本收益为0.16美元。机构评级:截至2025年3月9日,当前有6家机构对Tg Therapeutics, Inc.目标价做出预测,其中目标均价为42.83美元,其中最低目标价为10.00美元,最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230a266b3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230a266b3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ"],"gpt_icon":0},{"id":"2517162677","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162677?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277052,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分,Tg Therapeutics, Inc.股票出现波动,股价快速拉升5.04%。截至发稿,该股报36.88美元/股,成交量108.177万股,换手率0.69%,振幅6.61%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000412989ec607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000412989ec607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TGTX","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2516711677","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516711677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516711677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:37","pubTimestamp":1741099069,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时37分,Tg Therapeutics, Inc.股票出现波动,股价急速拉升5.00%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1090.78%、1079.98%、427.26%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Pliant Therapeutics, Inc.,振幅分别为23.30%、22.25%、14.49%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223749abe7f1dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223749abe7f1dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","BK4588","TGTX","BK4139"],"gpt_icon":0},{"id":"1131727124","title":"TG Therapeutics 2024年第四季度GAAP每股收益$0.15,与预期一致,销售额$108.19M超$99.95M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1131727124","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131727124?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741004021,"startTime":"0","endTime":"0","summary":"TG Therapeutics公布季度每股收益为$0.15,符合分析师的一致预期。公司本季度销售额为$108.19百万,超过分析师预期的$99.95百万,超出8.24%。与去年同期的$43.97百万销售额相比,这是一个146.04%的增长。以上内容来自Benzinga Earnings专栏,原文如下:TG $Therapeutics$ reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. This is a 250 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $108.19 million which beat the analyst consensus estimate of $99.95 million by 8.24 percent. This is a 146.04","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX","TG"],"gpt_icon":0},{"id":"2516301606","title":"Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301606?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:50","pubTimestamp":1740775803,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时50分,Tg Therapeutics, Inc.股票出现异动,股价急速拉升5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045003abe13d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045003abe13d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","TGTX","BK4585","LENZ"],"gpt_icon":0},{"id":"2514703346","title":"Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703346?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:22","pubTimestamp":1740428567,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时22分,Tg Therapeutics, Inc.股票出现波动,股价大幅跳水5.12%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为327.09%、142.18%、41.18%,振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为176.22%、162.04%、81.92%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504224798913a0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504224798913a0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","TGTX","LENZ","BK4585"],"gpt_icon":0},{"id":"2508997936","title":"Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508997936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508997936?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:54","pubTimestamp":1738356887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时54分,Tg Therapeutics, Inc.股票出现异动,股价快速跳水5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045447a2358435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045447a2358435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","TGTX","BK4588","LENZ","BK4139"],"gpt_icon":0},{"id":"2506309359","title":"Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506309359?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991499,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分,Tg Therapeutics, Inc.股票出现波动,股价急速拉升5.05%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.32%。其相关个股中,Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃,换手率分别为1801.77%、202.36%、197.33%,振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Dogwood Therapeutics, Inc.,振幅分别为85.35%、65.16%、61.84%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232459961241f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232459961241f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2506941228","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.03%报30.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506941228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506941228?lang=zh_cn&edition=full","pubTime":"2025-01-25 02:55","pubTimestamp":1737744942,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日02时55分,Tg Therapeutics, Inc.股票出现异动,股价快速上涨5.03%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Neuphoria Therapeutics Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为4273.07%、2353.10%、1709.92%,振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As,振幅分别为261.67%、185.76%、137.09%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125025542a22e91e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125025542a22e91e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","LENZ","TGTX"],"gpt_icon":0},{"id":"2503157971","title":"Tg Therapeutics, Inc.盘中异动 股价大涨7.17%报29.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503157971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503157971?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:31","pubTimestamp":1736865072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时31分,Tg Therapeutics, Inc.股票出现异动,股价快速上涨7.17%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Soligenix, Inc.、Phio Pharmaceuticals Corp.、Eterna Therapeutics Inc.较为活跃,换手率分别为345.84%、198.22%、101.37%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pasithea Therapeutics Corp.、Eterna Therapeutics Inc.,振幅分别为13.30%、8.78%、8.61%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223112a221b81b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223112a221b81b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4139","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"2503587932","title":"Tg Therapeutics, Inc.盘中异动 早盘急速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503587932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503587932?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:24","pubTimestamp":1736785495,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时24分,Tg Therapeutics, Inc.股票出现异动,股价大幅下挫5.06%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。其相关个股中,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃,换手率分别为11688.76%、6418.13%、434.95%,振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.,振幅分别为336.09%、216.61%、185.36%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114002455960266b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114002455960266b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","LENZ","TGTX"],"gpt_icon":0},{"id":"2493425089","title":"Tg Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报32.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493425089?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:58","pubTimestamp":1734710288,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时58分,Tg Therapeutics, Inc.股票出现波动,股价大幅拉升5.01%。截至发稿,该股报32.50美元/股,成交量63.4669万股,换手率0.41%,振幅6.33%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023580895ea9e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023580895ea9e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4139","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"2492158048","title":"Tg Therapeutics, Inc.盘中异动 股价大跌5.03%报31.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492158048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492158048?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:42","pubTimestamp":1734550968,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时42分,Tg Therapeutics, Inc.股票出现异动,股价急速下挫5.03%。截至发稿,该股报31.88美元/股,成交量95.4473万股,换手率0.61%,振幅5.95%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.68%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219034249984cb723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219034249984cb723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2488497566","title":"Tg Therapeutics, Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488497566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488497566?lang=zh_cn&edition=full","pubTime":"2024-12-04 04:17","pubTimestamp":1733257025,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日04时17分,Tg Therapeutics, Inc.股票出现波动,股价急速下挫5.06%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.93%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Renovaro Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Purple Biotech Ltd、Nls Pharmaceutics Ltd.较为活跃,换手率分别为175.22%、157.46%、149.58%,振幅较大的相关个股有Jupiter Neurosciences Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为134.75%、69.23%、59.76%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204041705abf38c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204041705abf38c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2486038495","title":"Tg Therapeutics, Inc.盘中异动 快速上涨5.05%报36.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038495?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545213,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分,Tg Therapeutics, Inc.股票出现异动,股价快速上涨5.05%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.06%。其相关个股中,Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为87.03%、61.26%、38.40%,振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc,振幅分别为105.47%、105.26%、105.01%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522333498e44657&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522333498e44657&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","TGTX","BK4588","LENZ","BK4139"],"gpt_icon":0},{"id":"2483839116","title":"Tg Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报32.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483839116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483839116?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:28","pubTimestamp":1731515300,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时28分,Tg Therapeutics, Inc.股票出现异动,股价大幅上涨5.65%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002820971a6568&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002820971a6568&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TGTX","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"1181694956","title":"异动解读 | TG Therapeutics Inc.股价大涨5.28% 业绩和产品线发展或为推手","url":"https://stock-news.laohu8.com/highlight/detail?id=1181694956","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181694956?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:56","pubTimestamp":1731336994,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.公司今日盘中股价大涨5.28%,引发市场关注。公司近期没有重大利好消息公布,但从公司最新财报和产品线情况来看,可能是股价上涨的推手。另外,公司旗舰产品BRIUMVI已获FDA批准用于治疗复发性多发性硬化症,且公司在B细胞疾病领域还有潜在产品线在开发。如果新药研发取得进展,将为公司带来长期增长动力。因此,良好的业绩表现和产品线发展可能是推动股价上涨的主因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | TG Therapeutics Inc.股价大涨5.28% 业绩和产品线发展或为推手","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"2482773872","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.14%报30.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482773872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482773872?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:38","pubTimestamp":1731335928,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时38分,Tg Therapeutics, Inc.股票出现波动,股价大幅拉升5.14%。截至发稿,该股报30.29美元/股,成交量30.44万股,换手率0.20%,振幅3.02%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223848971a5b3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223848971a5b3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4585","LENZ","BK4588","BK4139"],"gpt_icon":0},{"id":"2482076374","title":"Tg Therapeutics, Inc.2024财年第三财季实现净利润3.88百万美元,同比减少96.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482076374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482076374?lang=zh_cn&edition=full","pubTime":"2024-11-10 08:02","pubTimestamp":1731196941,"startTime":"0","endTime":"0","summary":"11月10日,Tg Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为3.88百万美元,同比减少96.60%;其中营业收入为83.88百万美元,同比减少49.47%,每股基本收益为0.03美元。机构评级:截至2024年11月10日,当前有9家机构对Tg Therapeutics, Inc.目标价做出预测,其中目标均价为37.22美元,其中最低目标价为9.00美元,最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110080231abb1a2e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110080231abb1a2e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tgtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0266},{"period":"1month","weight":-0.1163},{"period":"3month","weight":0.3037},{"period":"6month","weight":0.6361},{"period":"1year","weight":1.6943},{"period":"ytd","weight":0.2621}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司,专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外,TG还获得了美国食品药品监督管理局(FDA)的BRIUMVI(ublituximab-xiiy)批准,用于治疗成人复发性多发性硬化症(RMS)患者,包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.05545},{"month":2,"riseRate":0.666667,"avgChangeRate":0.075535},{"month":3,"riseRate":0.666667,"avgChangeRate":0.113076},{"month":4,"riseRate":0.333333,"avgChangeRate":0.004697},{"month":5,"riseRate":0.545455,"avgChangeRate":0.017012},{"month":6,"riseRate":0.5,"avgChangeRate":0.057765},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.000866},{"month":8,"riseRate":0.583333,"avgChangeRate":-0.018713},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.054488},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.063094},{"month":11,"riseRate":0.916667,"avgChangeRate":0.190893},{"month":12,"riseRate":0.5,"avgChangeRate":0.112059}],"exchange":"NASDAQ","name":"TG Therapeutics Inc.","nameEN":"TG Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TG Therapeutics Inc.,TGTX,TG Therapeutics Inc.股票,TG Therapeutics Inc.股票老虎,TG Therapeutics Inc.股票老虎国际,TG Therapeutics Inc.行情,TG Therapeutics Inc.股票行情,TG Therapeutics Inc.股价,TG Therapeutics Inc.股市,TG Therapeutics Inc.股票价格,TG Therapeutics Inc.股票交易,TG Therapeutics Inc.股票购买,TG Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}